Literal source text
Lobbying issues and bill citations
BUD · Budget/Appropriations
H.R.1968 - Full Year Continuing Appropriations and Extensions Act; a bill to provide continuing FY2025 appropriations for federal agencies and extends various expiring programs; all provisions including funding for biomedical research, social determinants of health, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding and workforce, and related cancer services FY25 Labor, HHS, and Education appropriation bill related to funding for biomedical research, social determinants of health, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding workforce and related cancer services H Con Res 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; provisions pertaining to health program funding S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; all provisions pertaining to health program funding
Literal federal measure citations: H.R.1968, H Con Res 14, S.Con.Res.7
INS · Insurance
Efforts to reintroduce the Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance Implementation of the Affordable Care Act and policies related to the extension of Advanced Enhanced Premium Tax Credits S.864 - Help Ensure Lower Patient (HELP) Copays Act; a bill to amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. All provisions addressing copay accumulator programs H.R.247/S.46 - Health Care Affordability Act of 2025; a bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan. All provisions requiring extension of the ACA enhanced advanced premium tax credits
Literal federal measure citations: S.864, H.R.247, S.46
MMM · Medicare/Medicaid
H.R.842/S.339 - Medicare Multi-Cancer Early Detection Screening Coverage Act; a bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests Proposed waivers under Sections 1115 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to telehealth benefits and access for Medicare beneficiaries Policies related to the preservation of the structure and funding of Medicaid Activities related to feedback on the Selected Drug List for Initial Price Applicability Years (IPAYs) 2026 and 2027 Comments related to Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
Literal federal measure citations: H.R.842, S.339
DEF · Defense
H.R.1968 - Full Year Continuing Appropriations and Extensions Act; a bill to provide continuing FY2025 appropriations for federal agencies and extends various expiring programs; all provisions including funding for the congressionally-directed medical research program, especially those relating to breast cancer
Literal federal measure citations: H.R.1968
HCR · Health Issues
Efforts to reintroduce the Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program Policies related to sterile injectable medications shortages Comments related to Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1124-N, 89 Fed. Reg. 93545 Policies related to PBM and drug cost transparency Efforts related to proposed reductions in force and rescission of the Richardson Waiver at the Department of Health and Human Services
